Aryl Hydrocarbon Receptor Activation Promotes Effector CD4+ T Cell Homeostasis and Restrains Salt-Sensitive Hypertension
Excess dietary salt and salt-sensitivity contribute to cardiovascular disease. Distinct T cell phenotypic responses to high salt and hypertension, as well as influences from environmental cues, are not well understood. The aryl hydrocarbon receptor (AhR) is activated by dietary ligands, promoting T cell and systemic homeostasis. We hypothesized that activating AhR supports CD4+ homeostatic functions, such as cytokine production and mobilization, in response to high salt intake while mitigating salt-sensitive hypertension. In the intestinal mucosa, we demonstrate that a high-salt diet (HSD) is a key driving factor, independent of hypertension, in diminishing interleukin 17A (IL-17A) production by CD4+ T (Th17) cells without disrupting circulating cytokines associated with Th17 function. Previous studies suggest that hypertensive patients and individuals on a HSD are deficient in AhR ligands or agonistic metabolites. We found that activating AhR augments Th17 cells during experimental salt-sensitive hypertension. Further, we demonstrate that activating AhR in vitro contributes to sustaining Th17 cells in the setting of excess salt. Using photoconvertible Kikume Green-Red mice, we also revealed that HSD drives CD4+ T cell mobilization. Next, we found that excess salt augments T cell mobilization markers, validating HSD-driven T cell migration. Also, we found that activating AhR mitigates HSD-induced T cell migration markers. Using telemetry in a model of experimental salt-sensitivity, we found that activating AhR prevents the development of salt-sensitive hypertension. Collectively, stimulating AhR through dietary ligands facilitates immunologic and systemic functions amid excess salt intake and restrains the development of salt-sensitive hypertension.
Authors
- Troy D. Randall (ORCID: https://orcid.org/0000-0003-0643-0311)
- Jennifer S. Pollock (ORCID: https://orcid.org/0000-0003-1956-0449)
- Melissa Jennings (ORCID: https://orcid.org/0000-0002-6814-8525)
- Davide Botta (ORCID: https://orcid.org/0000-0003-3926-0662)
- Jackson Colson
- Selene Meza‐Perez (ORCID: https://orcid.org/0000-0001-7881-6964)
- Laurie E. Harrington (ORCID: https://orcid.org/0000-0002-6832-9529)
- Cailin Kellum (ORCID: https://orcid.org/0000-0003-0113-6711)
- Craig L. Maynard (ORCID: https://orcid.org/0000-0001-5876-8168)
- Ashlyn A. Buzzelli (ORCID: https://orcid.org/0000-0002-1704-3619)
- Carmen De Miguel (ORCID: https://orcid.org/0000-0002-2323-3670)
- Patrick A. Molina (ORCID: https://orcid.org/0000-0001-8855-0880)
- Claudia Edell
- Rachel Q Muir (ORCID: https://orcid.org/0000-0002-7671-0776)
- David M. Pollock (ORCID: https://orcid.org/0000-0002-0233-2362)
- Dominik N. Müller (ORCID: https://orcid.org/0000-0003-3650-5644)
- Luke S. Dunaway (ORCID: https://orcid.org/0000-0002-7458-9669)
- Megan K Rhoads (ORCID: https://orcid.org/0000-0001-7494-9815)
Institutions
- Max Delbrück Center (DE)
- University of Alabama at Birmingham (US)
- Humboldt-Universität zu Berlin (DE)
- Pediatric Nephrology of Alabama (US)
- Metabolism and Renal Physiology (FR)
- Center for Rheumatology (US)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Function
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/function/zqaf001
- Citations
- 4
- Primary Topic
- Sodium Intake and Health
- Type
- article
- Field-Weighted Citation Impact
- 4.48
Funders
- Deutsches Zentrum für Herz-Kreislaufforschung
- Crohn's and Colitis Foundation
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- University of California, San Diego